Perineal saturation biopsy of the prostate


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The effectiveness of perineal biopsy for the detection of prostate cancer (PC) using an array for brachytherapy/cryotherapy was evaluated. It is shown that perineal saturation biopsy provides high detection rate of prostate cancer in patients with suspected cancer after negative transrectal biopsies, does not increase the detection of clinically insignificant cancer and incidence of complications, but requires a lot of time and cost.

全文:

受限制的访问

作者简介

A. Sadchenko

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Email: doc.sadchenko@yandex.ru
Department of Urology

A. Govorov

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Department of Urology

D. Pushkar

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Department of Urology

A. Sidorenkov

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Department of Urology

A. Vasilyev

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Department of Urology

M. Kovylina

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Department of Urology

E. Prilepskaya

Moscow State Medical Stomatological University n.a. A.I. Evdokimov

Department of Urology

参考

  1. Jemal A., Siegel R., Ward E. et al. Cancer statistics. 2012. CA Cancer J Clin. 2012; 62(1): 10-29.
  2. Frankel S., Smith G.D., Donovan J. et al. Screening for prostate cancer. Lancet 2003; 361: 1122-1128.
  3. Norberg M., Egevad L., Bolmberg L. et al. The sextant protocol for ultrasound guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997; 50: 562-566.
  4. Simon J., Kuefer R., Bartsch G. Jr., et al. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int. 2009; 102: 459-462.
  5. Jones J.S. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int. 2007; 99: 1340-1344.
  6. Пушкарь Д.Ю., Говоров А.В. Биопсия предстательной железы. М. ГЭОТАР-Медиа., 2010; 208.
  7. Djavan B., Ravery V., Zlotta A. et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol. 2001; 166: 1679-1683.
  8. Borboroglu P.G., Comer S.W., Riffenburgh R.H. et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000; 163: 158-162.
  9. Walz J., Graefen M., Chun F.K. et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur. Urol. 2006; 50: 498-505.
  10. Stewart C.S., Leibovich B.C., Weaver A.L. et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001; 166: 86-92.
  11. Demura T., Hioka T., Furuno T. et al. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer. 2005; 103: 1826-1832.
  12. Hara R., Jo Y., Fujii T. et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. J Urol. 2008; 71: 191-195.
  13. Li H., Yan W., Zhou Y. Transperineal ultrasound- guided saturation biopsies using 11-region template of prostate: report of 303 cases. J Urol. 2007; 70: 1157-1161.
  14. Bott S.R., Henderson A., Halls J.E. et al. Extensive transperineal template biopsies of prostate: modifi ed technique and results. J Urol 2006; 68: 1037 -1041.
  15. Bott S.R., Henderson A., Parkinson M.C. et al. Setting up a prostate cancer database: experiences on how to get out more than you put in. BJU Int. 2003; 92: 665-666.
  16. Novara G., Boscolo-Berto R., Lamon C. et al. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate. BJU Int. 2010; 105: 1242-1246.
  17. Abdollah F., Novara G., Briganti A. et al. Transrectal versus transperineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? J Urol. 2011; 77: 921-925.
  18. Moran B.J., Braccioforte M.H. Stereotactic transperineal prostate biopsy. J Urol. 2009; 73: 386-388.
  19. Bott S.R., Henderson A., McLarty E. et al. A brachytherapy template approach to standardize saturation prostatic biopsy. BJU Int. 2004; 93: 629-630.
  20. Barzell W.E., Melamed M.R. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate - a 4-year experience. J Urol. 2007; 70: 27-35.
  21. Onik G., Miessau M., Bostwick D.G. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol. 2009; 27: 4321-4326.
  22. Taira A.V., Merrick G.S., Galbreath R.W. et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 2010; 13: 71-77.
  23. Bittner N., Merrick G.S., Andreini H. et al. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. J Urol. 2009; 74: 171-176.
  24. Jones J.S. Prostate cancer: are we over diagnosing - or under-thinking? Eur. Urol. 2008; 53: 10-12.
  25. Fleshner N., Klotz L. Role of “saturation biopsy” in the detection of prostate cancer among diffi cult diagnostic cases. J Urol. 2002; 60: 93-97.
  26. Artibani W., Rigatti P., Montorsi F. et al. Transrectal versus transperineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? J Urol. 2011; 77: 921-925.
  27. Merrick G.S., Taubenslag W., Andreini H. et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008; 101(12): 1524-1529.
  28. Bittner N., Merrick G.S., Stewart R. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate. Urol. Oncol. 2011; 29(4): 398-404.
  29. Patel V., Merrick G.S., Allen Z.A. et al. The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning. J Urol. 2011; 77(5): 1148-1152.
  30. Pepe P., Aragona F. Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy? Urol. Int. 2011; 87(2): 171-174.
  31. Dimmen M., Vlatkovic L., Hole K.H. et al. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int. 2012; 110 (2 Pt 2): 69-75.
  32. Pal R.P., Elmussareh M., Chanawani M. et al. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int. 2012; 109 (3): 367-371.
  33. Gershman B., Zietman A.L., Feldman A.S. et al. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol. Oncol. 2012; Feb 3. [Epub ahead of print].
  34. Mabjeesh N.J., Lidawi G., Chen J. et al. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int. 2012; 110 (7): 993-997.
  35. Zhang F.B., Shao Q., Du Y. et al. Ultrasound-guided transperineal 24-core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA № 20 microg/L. Zhonghua Nan Ke Xue 2012; 18(4): 306-309.
  36. Bittner N., Merrick G.S., Butler W.M. et al. Incidence And Pathologic Features Of Prostate Cancer Detected On Transperineal Template-Guided Mapping Biopsy Following Negative Transrectal Ultrasound-Guided Biopsy. J Urol. 2013 Feb 14. pii: S0022-5347(13)00290-5. doi: 10.1016/j.juro.2013
  37. Symons J.L., Huo A., Yuen C.L. et al. Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU Int 2013; Apr 3. [Epub ahead of print].
  38. Hossack T., Patel M.I., Huo A. et al. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol. 2012; 188: 781-785.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2014
##common.cookie##